颅内椎动脉夹层动脉瘤血管内治疗的围手术期脑血管并发症及30天结局
该研究纳入195例患者共198个颅内椎动脉夹层动脉瘤,评估血管内治疗的围手术期脑血管并发症及30天结局。并发症率为11.1%(22/198),高脂血症、缺血性卒中史和蛛网膜下腔出血是总体并发症的独立危险因素,动脉瘤高度为保护因素。术前mRS评分>2和围手术期并发症是30天不良临床结局的独立危险因素。
要点
- 高脂血症、缺血性卒中史和蛛网膜下腔出血是围手术期总体并发症的独立危险因素。
- 动脉瘤高度是围手术期总体并发症的独立保护因素(OR 0.77)。
- 术前mRS评分>2和围手术期并发症是30天不良临床结局的独立危险因素。
核心结论
- 高脂血症、缺血性卒中史和蛛网膜下腔出血是颅内椎动脉夹层动脉瘤血管内治疗围手术期总体脑血管并发症的独立预测因素,动脉瘤高度是独立保护因素。
- 蛛网膜下腔出血和术前mRS评分>2是穿支闭塞性卒中的独立危险因素。
- 术前mRS评分>2和围手术期并发症是30天不良临床结局的独立危险因素。
研究设计与样本
- 该研究纳入195例患者共198个颅内椎动脉夹层动脉瘤,均接受血管内治疗。
- 记录临床资料、形态学特征、治疗细节及围手术期脑血管并发症(包括术中破裂、术中血栓形成、颅内出血、短暂性脑缺血发作和缺血性卒中)。
- 评估30天改良Rankin量表评分,应用单因素和多因素logistic回归分析识别并发症及30天不良临床结局的危险因素。
主要发现
- 无术中破裂发生,记录到术中血栓形成5例、颅内出血3例、短暂性脑缺血发作1例、缺血性卒中13例,并发症率为11.1%(22/198)。
- 多因素logistic回归显示,高脂血症(OR 3.17,95%CI 1.20-8.41,p=0.020)、缺血性卒中史(OR 5.55,95%CI 1.46-21.01,p=0.012)和蛛网膜下腔出血(OR 4.48,95%CI 1.52-13.20,p=0.007)是总体并发症的危险因素,动脉瘤高度(OR 0.77,95%CI 0.61-0.98,p=0.032)是保护因素。
- 蛛网膜下腔出血(OR 6.44,95%CI 1.54-26.89,p=0.011)和术前mRS评分>2(OR 5.07,95%CI 1.01-25.59,p=0.049)是穿支闭塞性卒中的独立危险因素。
- 围手术期脑血管并发症(OR 32.09,95%CI 3.00-343.94,p=0.004)和术前mRS评分>2(OR 319.92,95%CI 30.28-3379.98,p<0.001)是30天不良临床结局的独立危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors undertook an evaluation of periprocedural cerebrovascular complications and 30-day outcomes of endovascular treatment for intracranial vertebral artery dissecting aneurysms (IVADAs) and assessed the relevant risk factors. METHODS: The authors included a series of 195 patients who had undergone endovascular treatment for 198 IVADAs. Clinical data, morphological characteristics, treatment details, and periprocedural cerebrovascular complications including intraprocedural rupture, intraprocedural thrombosis, intracranial hemorrhage (ICH), transient ischemic attack (TIA), and ischemic stroke (IS) were recorded. After evaluation of the 30-day modified Rankin Scale (mRS) scores, the authors applied univariate and multivariate logistic regression analyses to identify the risk factors for complications and 30-day unfavorable clinical outcomes. RESULTS: There were no intraprocedural ruptures, but the authors recorded intraprocedural thrombosis (n = 5), ICH (n = 3), TIA (n = 1), and IS (n = 13), comprising an 11.1% (22/198) complication rate. Multivariate logistic regression analysis indicated that hyperlipidemia (odds ratio [OR] 3.17, 95% confidence interval [CI] 1.20-8.41, p = 0.020), IS history (OR 5.55, 95% CI 1.46-21.01, p = 0.012), and subarachnoid hemorrhage (SAH) (OR 4.48, 95% CI 1.52-13.20, p = 0.007) were risk factors for overall complications, whereas aneurysmal height (OR 0.77, 95% CI 0.61-0.98, p = 0.032) was a protective factor. SAH (OR 6.44, 95% CI 1.54-26.89, p = 0.011) and preprocedural mRS score > 2 (OR 5.07, 95% CI 1.01-25.59, p = 0.049) were independent risk factors for perforator occlusion stroke. Periprocedural cerebrovascular complications (OR 32.09, 95% CI 3.00-343.94, p = 0.004) and preprocedural mRS score > 2 (OR 319.92, 95% CI 30.28-3379.98, p < 0.001) were independent risk factors for 30-day unfavorable clinical outcomes. CONCLUSIONS: Hyperlipidemia, IS history, and SAH were independent predictors for overall periprocedural cerebrovascular complications of endovascular treatment for IVADAs, but aneurysmal height was an independent protective factor. SAH and preprocedural mRS score > 2 were independent risk factors for perforator occlusion stroke. Preprocedural mRS score > 2 and periprocedural complications were independent risk factors for 30-day unfavorable clinical outcomes.
引用
- Han J, Liu F, Chen J, et al. Periprocedural cerebrovascular complications and 30-day outcomes of endovascular treatment for intracranial vertebral artery dissecting aneurysms. J Neurosurg. 2022. PMID: 36401540. doi:10.3171/2022.10.JNS221953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。